GU Cancers 2020 | Chemo eligibility: bladder cancer
Thanks for your feedback, this will help us improve our content for you!
Srikala Sridhar, MD, MSc, FRCPC, Princess Margaret Hospital, Toronto, ON, Canada, discusses whether it is necessary to redefine cisplatin-ineligibility in metastatic urothelial cancer. This interview took place at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.
Get great new content delivered to your inboxSign up